Medically Integrated Dispensing Pharmacy: ASCO-NCODA (Network for Collaborative Oncology Development & Advancement) Standards Update

20250 citationsJournal Article

Authors

Luis E. Raez · Florida Atlantic University

Xylina T. Gregg · Utah Cancer Specialists

Gurjyot K. Doshi · Texas Oncology

Scott Freeswick · Memorial Sloan Kettering Cancer Center

Adrienne D. Cox · Florida Cancer Specialists & Research Institute

Neal Dave · Texas Oncology

Kashyap Patel

Abstract

These revised and expanded ASCO-Network for Collaborative Oncology Development & Advancement standards further enhance existing guidance to practices and outpatient clinics engaging in or planning to initiate MIP. The goal is to improve clinical outcomes and patient satisfaction through adherence to rigorous standards in oral anticancer medication management, patient safety, and care coordination.Additional information is available at www.asco.org/standards.

Topics & Keywords

Pharmaceutical Practices and Patient Outcomes Economic and Financial Impacts of Cancer Medication Adherence and Compliance

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: JCO Oncology Practice

Volume 21, Issue 11, pp. 1567-1581

DOI: 10.1200/op-25-00279

Field-Weighted Citation Impact: 0.00

Command Palette